Epidemiology and prevention of hepatitis B virus infection in China

Journal of Viral Hepatitis

Volumn 17, Issue SUPPL. 1, 2010, Pages 4-9

  Lu, F M ^a   Li, T ^a   Liu, S ^b   Zhuang, H ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Epidemiology; Hepatitis B virus; Prevention; Transmission; Vaccine

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

BABY; CHINA; DEVELOPING COUNTRY; DISEASE CONTROL; ENDEMIC DISEASE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; INCIDENCE; LIVER CELL CARCINOMA; MORBIDITY; MORTALITY; POPULATION; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REVIEW; VACCINATION; VIRUS TRANSMISSION;

CHINA; DEVELOPING COUNTRIES; ENDEMIC DISEASES; HEALTH POLICY; HEPATITIS B; HEPATITIS B VACCINES; PREVALENCE;

EID: 77749317108     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2010.01266.x     Document Type: Review

References (41)

1. Tao CM, Huang TY, Feng PF et al. A preliminary study on hepatitis B vaccine. Chin Med J (Engl) 1978 4 : 101 110.
2. Buynak EB, Roehm RR, Tytell AA, Bertland AU, Lampson GP, Hilleman MR. Vaccine against human hepatitis B. JAMA 1976 235 : 2832 2834.
3. Mo ZJ, Shen LP, Yang JY et al. Study on the relationship between hepatitis B vaccination and sero-epidemiology of infective status of hepatitis B virus. Chin J Vaccine Immun (Chin) 2007 13 : 216 218.
4. Tian C, Ma JC, Han CZ et al. Infective status of HBV among population after 19 years immunization vaccine. Chin J Vaccine Immun (Chin) 2007 13 : 4 7.
5. Liang X, Bi S, Yang W et al. Epidemiological serosurvey of hepatitis B in China - Declining HBV prevalence due to Hepatitis B vaccination. Vaccine 2009 27 : 6550 6557.
6. Zhuang H. Challenge of chronic hepatitis B in China. Chin J Infect Dis (Chin) 2005 23 (Suppl. 2 5.
7. Zhang J, Zhao Z, Shao X, Zou Y. Hepatitis B seroepidemic survey in Guangdong province in 2006. South China J Prev Med (Chin) 2009 35 : 38 40.
8. Lu F, Zhuang H. Management of hepatitits B in China. Chin Med J (Engl) 2009 122 : 3 4.
9. Qu ZY. An epidemiological study on the distribution of HBsAg and anti-HBs in China. Chinese J Microbiol Immunol (Chin) 1986 6 : S20 S40.
10. Hu ZH, Qu ZY, Jing Q et al. The overall infection rate of HBV in Chinese general population by sampling investigation. Chinese J Microbiol Immunol (Chin) 1986 6 : S70 S77.
11. Liu CB, Xu ZY, Cao HL et al. Sero-epidemiology of HBV infection in four provinces in China. Chinese J Virol (Chin) 1991 7 : S8 S14.
12. Xia GL, Liu CB, Cao HL et al. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D and E virus infections in China, 1992. Int Hepatol Commun 1996 5 : 62 73.
13. Dai ZC, Qi GM. Seroepidemiological Survey on Viral Hepatitis in China (part one), 1st edn. Beijing : Sci Tech Literature Publishing House, 1997 59.
14. Liang X, Bi S, Yang W et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis 2009 200 : 39 47.
15. Data on 2006 seroepidemiological survey on HBV infection in China. Available at http://www.moh.gov.cn (accessed 21 April 2008).
16. Wang FZ, Cui FQ, Lu Y et al. Analysis on reported hepatitis B cases on pilot surveillance in 18 counties of 8 provinces of China. Chin J Vaccine Immun (Chin) 2007 13 : 309 331.
17. Cui FQ, Wang XJ, Liang XF. Epidemiological analysis on reported hepatitis B under 15 years in China: the report from Chinese Center for Disease Control and Prevention. Chin J Vaccine Immun (Chin) 2006 12 : 206 208.
18. Zhou YH, Wu C, Zhuang H. Vaccination against hepatitis B: the Chinese experience. Chin Med J (Engl) 2008 121 : 98 102.
19. Gong XH, Liu LR, Jia L, Li YH, Xing YL, Wang QY. Epidemiological effect of hepatitis B immunization among newborn babies in Beijing. Chin J Hepatol (Chin) 2003 11 : 201 202.
20. Zhang HW, Yin JH, Li YT et al. Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China. Gut 2008 57 : 1713 1720.
21. Gong J, Li RC, Yang JY et al. Long-term efficacy of infant hepatitis B immunization program. Chin J Hepatol (Chin) 2003 11 : 203 205.
22. Wang ST, Wong XZ. Report of 5 cases of post transfusion serum hepatitis. J Peking Univ (Health Sci) (Chin) 1960 2 : 63 66.
23. Shang G, Seed CR, Wang F, Nie D, Farrugia A. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. Transfusion 2007 47 : 529 539.
24. Liang RL, Su QT. A study on HBV horizontal transmission between spouses. Zhong Hua Liu Xing Bing Xue Za Zhi 1984 5 (6 372 374.
25. Alter MJ, Margolis HS. The emergence of hepatitis B as a sexually transmitted disease. Med Clin North Am 1990 74 : 1529 1541.
26. Wu Q, Li Z, Fan J. A seroepidemiological study on sexually transmitted HBV infection. Chin J Epidemiol (Chin) 1994 15 : 67 70.
27. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004 11 : 97 107.
28. Jia JD. Hepatitis B in China: from Guideline to Practice. Virol Sin 2008 23 : 152 155.
29. Hou J, Liu Z, Gu F. Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci 2005 2 : 50 57.
30. Zhu JM, Li BK. Current status of unsafe injection of Chinese countryside. Chin J Dis Control Prev (Chin) 2004 8 : 247 249.
31. Murakami H, Kobayashi M, Zhu X et al. Risk of transmission of hepatitis B virus through childhood immunization in northwestern China. Soc Sci Med 2003 57 : 1821 1823.
32. Zuo JT, Zhong G, Lan GH et al. Epidemiological retrospective experimental study on HBV transmission with unsafe injection in Guangxi, China. Chin J Vaccine Immun (Chin) 2006 12 : 140 142.
33. Wang NS, Lan YJ, Tang LQ, Liao FT. Analysis of hepatitis B virus and hepatitis C virus infection in patients with maintenance hemodialysis. Chin J Nephrol (Chin) 1998 14 : 376 379.
34. Ma LL, Sun Y, Li XW. An epidemiology study of HBV infection in hemodialysis center. Chin J Blood Purif (Chin) 2006 5 : 265 268.
35. Hsu YS, Chien RN, Yeh CT et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002 35 : 1522 1527.
36. Yang HI, Lu SN, Liaw YF et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002 347 : 168 174.
37. Yang CG, Yu LC, Chen JJ et al. A comparison of clinical and virological characteristics of 1686 cases of HBeAg negative and HBeAg positive chronic hepatitis B. Chin J Intern Med (Chin) 2005 44 : 648 651.
38. Lin HH, Wang LY, Hu CT et al. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. J Med Virol 2003 69 : 471 474.
39. Chang MH, Chen CJ, Lai MS et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997 336 : 1855 1859.
40. Li RC, Yang JY, Gong J et al. Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma. Chin J Epidemiol (Chin) 2004 25 : 385 387.
41. Lu FM, Zhuang H. Prevention of hepatitis B in China: achievements and challenges. Chin Med J (Engl) 2009 122 : 2925 2927.